Testing effectiveness (Phase 2)UnknownNCT02771743What this trial is testingResponse-based Treatment of High-risk NeuroblastomaWho this might be right forNewly Diagnosed High Risk Neuroblastoma Samsung Medical Center 54
Early research (Phase 1)Looking for participantsNCT06485947What this trial is testingStudy Combining Dinutuximab Beta With Two Chemotherapy Regimens in NeuroblastomaWho this might be right forNeuroblastoma Princess Maxima Center for Pediatric Oncology 38
Testing effectiveness (Phase 2)UnknownNCT00281905What this trial is testingCombination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain TumorsWho this might be right forBrain and Central Nervous System TumorsNeuroblastoma Children's Cancer and Leukaemia Group 50
Early research (Phase 1)Study completedNCT00070200What this trial is testingInduction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive NeuroblastomaWho this might be right forNeuroblastoma Children's Oncology Group 31
Testing effectiveness (Phase 2)Study completedNCT00003657What this trial is testingHigh-dose ICE With AmifostineWho this might be right forBladder CancerBrain and Central Nervous System TumorsCarcinoma of Unknown Primary+8 more Dana-Farber Cancer Institute 24
Large-scale testing (Phase 3)Ended earlyNCT01132547What this trial is testingCyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for CancerWho this might be right forCancer University of South Florida 22
Testing effectiveness (Phase 2)Looking for participantsNCT05489887What this trial is testingNaxitamab Added to Induction for Newly Diagnosed High-Risk NeuroblastomaWho this might be right forNeuroblastoma Giselle Sholler 93
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06948994What this trial is testingA Clinical Trial on Autologous NK Cells Combined With GD2 Monoclonal Antibody in the Treatment of Children With Newly Diagnosed High-risk or Relapsed/Refractory NeuroblastomaWho this might be right forNeuroblastomaGD2 AntibodyAutologous NK Cell Guangzhou Women and Children's Medical Center 15
Early research (Phase 1)Study completedNCT00003141What this trial is testingChemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord TumorsWho this might be right forBrain TumorsCentral Nervous System TumorsNeuroblastoma+1 more Children's Oncology Group 94
Not applicableStudy completedNCT00002485What this trial is testingDevelopment of Strategies to Increase Enrollment in Clinical Trials for Children With CancerWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more Children's Oncology Group 359
Testing effectiveness (Phase 2)Ended earlyNCT02641782What this trial is testingNB2013-HR German (GPOH) / Dutch (DCOG) TrialWho this might be right forNeuroblastoma University of Cologne 3
Testing effectiveness (Phase 2)Study completedNCT00003846What this trial is testingRadiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal TumorsWho this might be right forBrain and Central Nervous System TumorsNeuroblastoma Children's Oncology Group 25
Early research (Phase 1)Study completedNCT01175356What this trial is testingInduction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With IsotretinoinWho this might be right forGanglioneuroblastomaLocalized Resectable NeuroblastomaLocalized Unresectable Neuroblastoma+3 more Children's Oncology Group 99
Large-scale testing (Phase 3)Looking for participantsNCT06172296What this trial is testingDinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk NeuroblastomaWho this might be right forGanglioneuroblastoma, NodularNeuroblastoma National Cancer Institute (NCI) 478
Very early researchEnded earlyNCT00499733What this trial is testingCyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial CancerWho this might be right forCancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Not applicableWithdrawnNCT06335745What this trial is testingPediCARE Health Equity Intervention in High-Risk NeuroblastomaWho this might be right forNeuroblastomaHigh-risk NeuroblastomaPediatric Cancer+3 more Dana-Farber Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00005955What this trial is testingTemozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS TumorsWho this might be right forBrain and Central Nervous System TumorsNeuroblastoma Duke University
Testing effectiveness (Phase 2)Active Not RecruitingNCT03786783What this trial is testingDinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk NeuroblastomaWho this might be right forGanglioneuroblastomaHigh Risk Neuroblastoma National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Study completedNCT00003203What this trial is testingCarboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal TumorsWho this might be right forBrain TumorsCentral Nervous System TumorsNeuroblastoma Children's Oncology Group 168
Early research (Phase 1)Study completedNCT00638898What this trial is testingBusulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid TumorWho this might be right forSolid TumorAdult Central Nervous System Germ Cell TumorAdult Rhabdomyosarcoma+27 more City of Hope Medical Center 25